Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acetaminophen Boosts Liver Toxicity Alone, As Combination Therapy – JAMA

This article was originally published in The Tan Sheet

Executive Summary

A study finding that the maximum recommended OTC dose of acetaminophen increased the risk of liver toxicity when used both alone and in combination with certain Rx opioids adds to existing concerns about the safety of the analgesic

You may also be interested in...



American Liver Foundation Issues Warning On Acetaminophen Intake Levels

A recent JAMA study linking acetaminophen intake at OTC doses to increased liver toxicity has prompted the American Liver Foundation (ALF) to warn consumers not to exceed intake of three grams of the drug a day for any prolonged period of time

American Liver Foundation Issues Warning On Acetaminophen Intake Levels

A recent JAMA study linking acetaminophen intake at OTC doses to increased liver toxicity has prompted the American Liver Foundation (ALF) to warn consumers not to exceed intake of three grams of the drug a day for any prolonged period of time

American Liver Foundation Issues Warning On Acetaminophen Intake Levels

A recent JAMA study linking acetaminophen intake at OTC doses to increased liver toxicity has prompted the American Liver Foundation (ALF) to warn consumers not to exceed intake of three grams of the drug a day for any prolonged period of time

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel